Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals has informed that a meeting of Board of Directors of the Company is scheduled to be held on Monday, 26th May, 2025, to consider and approve the Un-audited (Standalone & Consolidated) Financial Results for the quarter ended on 31st March, 2025 and Audited (Standalone & Consolidated) Financial statements for the year ended on 31st March, 2025.
The above information is a part of company’s filings submitted to BSE.
